Johanne Blais

5PUBLICATIONS
24CO-AUTHORS
Molecular medicineInfant and child healthChemotherapyInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2026
IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model.

|May 27, 2026
Development of a Phase 1 Cryptosporidiosis Controlled Human Challenge Model in Healthy Volunteers Using Current Good Manufacturing Practice Cryptosporidium Parvum Oocysts and Conducted Under an Investigational New Drug Application.

|Apr 12, 2026
A first-in-human phase 1 clinical study in healthy volunteers to assess the safety, tolerability and pharmacokinetics of EDI048, a novel promising agent to treat enteric cryptosporidiosis.

Monish Jain, Kristen Stevenson, Anais Cheblal

|Feb 18, 2026
Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical Use.

Rajiv S Jumani, Bryanna Thomas, Jay Lakshman

|Nov 30, 2022
In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor.

Johanne Blais, Charles R Dean, Guillaume Lapointe

Pageof 1

Frequent Collaborators

4 joint publications

Rajiv S Jumani

4 joint publications

Ujjini H Manjunatha

2 joint publications

Bridget D Stuart

2 joint publications

Joseph Etse